Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Reports Holding(s) in Company 9/2017

6 Sep 2017 07:00

RNS Number : 8924P
ProPhotonix Limited
06 September 2017
 

 

 

September 6, 2017

ProPhotonix Limited

("ProPhotonix" or the "Company")

Holding(s) in Company

ProPhotonix Limited (London Stock Exchange - AIM: PPIX & PPIR, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, announces recent changes in the Company's significant shareholders. On August 31, 2017, the 600 Group PLC ("600 Group") sold its entire interest of 22,042,143 common shares in the Company ("Common Shares"), representing approximately 24.3% of ProPhotonix's issued share capital.

In connection with the above sale, the following investors each acquired shares in the Company and holds more than 3% of the Company's issued share capital:

 Beneficial Owner

Number of Common Shares

Percentage of Voting Rights

Gresham House Strategic PLC

4,993,492

5.5%

Hargreave Hale LTD

4,993,492

5.5%

Herald Investment Management Limited

4,993,492

5.5%

Miton Group PLC

4,993,492

5.5%

The Company announced on August 21, 2017 the admission to trading on AIM of the Restricted Stock Line, PPIR. The Restricted Stock Line (as represented by Depository Interests) is held in the CREST system and is segregated into a separate trading system within CREST, identified with the marker "REGS" and ISIN USU743121142. The Restricted Stock Line enables holders of the shares, who are not United States Persons, to trade the shares within the CREST system and to ensure the shares do not trade to a United States Person, in accordance with Regulation S promulgated under the US Securities Act 1933 as amended ("Securities Act") during the distribution compliance period of one year from the date of acquisition by the buyers in the Sale, and until the applicable requirements of Rule 144 under the Securities Act are met. Neither the Sale nor the Restricted Stock Line has increased the number of issued and outstanding Common Shares, as all shares were already issued and outstanding, and the number of Common Shares issued and outstanding remains at 90,825,402.

 

Tim Losik, CEO and President of ProPhotonix stated, "We are delighted with the interest shown in ProPhotonix by our four new well regarded institutional shareholders. The strategy of the Company has shifted from capital repositioning and debt repayment, initiated in 2013, to investment for growth and the institutionalization of our shareholder register demonstrates strong support for this change in strategy."

Enquiries / Contacts

ProPhotonix Limited

Tim Losik, President and CEO Tel: +1 603 893 8778

ir@prophotonix.com

 

Stockdale Securities Limited

Tom Griffiths / David Coaten Tel: +44 (0) 20 7601 6100

Nominated Adviser and Broker

 

 

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly OCLARO), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGMGGLKKLGNZM
Date   Source Headline
13th Aug 20127:00 amRNSHalf Yearly Report
25th May 20122:30 pmRNSGrant of Options (Replacement)
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.